The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: I.v. antigen administration

International Immunology

Volumn 11, Issue 12, 1999, Pages 1889-1895

  Ratts, Robert B ^a   Arredondo, LaChelle R ^a   Bittner, Patrice ^a   Perrin, Peter J ^b   Lovett Racke, Amy E ^a   Racke, Michael K ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Co stimulatory molecules; Experimental autoimmune encephalomyelitis; Neuroimmunology; Tolerance

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FREUND ADJUVANT; INTERLEUKIN 2; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CLONAL ANERGY; CYTOKINE PRODUCTION; DRUG POTENTIATION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE CELL; LYMPHOCYTE CLONE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0033428882     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.12.1889     Document Type: Article

References (32)

1. June, C. H., Bluestone, J. A., Nadler L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
2. Jenkins, M. K. and Johnson, J. G. 1993. Molecules involved in T-cell co-stimulation. Curr. Opin. Immunol. 5:351.
3. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74.
4. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., Gray, G. S., Nadler, L. M. and Sharp, A. H. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
5. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J., Restivo, V. A., Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that co-stimulates human T cell proliferation. Science 262:909.
6. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. J. 1994. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J. Exp. Med. 180:631.
7. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F. and Nadler, L. M. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
8. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg J. M., Hathcock, K., Laszlo, G., Lombard, L. A., Wang, S., Gray, G. S., Nadler, L. M. and Sharpe, A. H. 1993. Murine B7-2, an alternative CTLA-4 counter-receptor that co-stimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185.
9. Green, J. M., Noel, P. J., Sperling, A. L., Walunas, T. L., Gray, G. S., Bluestone, J. A. and Thompson, C. B. 1994. Absence of 87-dependent responses in CD28-deficient mice. Immunity 1:501.
10. Perez, V., Parijs, L., Biuckians, A., Zheng, X., Strom, T. and Abbas, A. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:411.
11. Walunas, T. L. and Bluestone, J. A. 1999. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 160:3855.
12. Samoliova, E. B., Horton, J. L., Zhang, H., Khoury, S. J., Weiner, H. L. and Chen, Y. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Int. Immunol. 10:491.
13. Issazadeh, S., Zhang, M., Sayegh, M. H. and Khoury, S. J. 1999. Acquired thymic tolerance: role of CTLA-4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. J. Immunol. 162:761.
14. Martin, R., McFarland, H. F. and McFarlin, D. E. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
15. Zamvil, S. S. and Steinman, L. 1990. The lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579.
16. Murphy, E. E., Terres, G., Macatonia, S. E., Hsieh, C. S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K. and O'Garra, A. 1994. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 co-stimulation. J. Exp. Med. 180:223.
17. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. and Nadler, L. M. 1993. Human T cell clonal anergy is induced by antigen presentation in the absence of B7 co-stimulation. Proc. Natl Acad. Sci. USA 90:6586.
18. Perrin, P. J., Scott, D., Quigley, L., Albert, P. S., Feder, O., Gray, G. S., Abe, R., June, C. H. and Racke, M. K. 1995. The role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1481.
19. Racke, M. K., Scott, D. E., Quigley, L., Gray, G. S., Abe, R., June, C. H. and Perrin, P. J. 1995. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195.
20. Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C., Cannella, B., Raine, C. S., Goverman, J. and Lenardo, M. J. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263 1139.
21. Racke, M. K., Critchfield, J. M., Quigley, L., Cannella, B., Raine, C. S., McFarland, H. F. and Lenardo, M. J. 1996, Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann. Neurol. 39:46.
22. Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L. and Zaller, D. M. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.
23. α region. J. Neurosci. Res. 47:489.
24. Siklodi, B., Jacobs, R., Vandenbark, A. A. and Offner, H. 1998. Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2, and increased severity of EAE. J. Neurosci. Res. 52:750.
25. Deibler, G. E., Martenson, R. E. and Kies, M. W. 1972. Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep. Biochem. 2:139.
26. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405.
27. Yoshimoto, T. and Paul, W. E. 1994. CD4 pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
28. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
29. Ratts, R. B., Arredondo, L. R., Bittner, P., Perrin, P. J., Lovett-Racke, A. E. and Racke, M. K. (1999) The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis. i.p. antigen administration. Int. Immunol. 11:1881.
30. Parijs, L. V., Perez, V. L., Biuckians, A., Maki, R. G., London, C. A. and Abbas, A. K. 1997. Role of interleukin 12 and co-stimulators in T cell anergy in vivo. J. Exp. Med. 186:1119.
31. Ceredig, R. and Corradin, G. 1986. High antigen concentration inhibits T cell proliferation but not IL-2 production: examination of limiting dilution microcultures and T cell clones. Eur. J. Immunol. 16:30.
32. h1 cells. J. Immunol. 161:2168.